Further, we compared the expression levels of the immune checkpoints and found that low-risk BRCA patients have higher CD274 (Fig. 5B), PDCD1 (Fig. 5C), and CTLA4 (Fig. 5D) expression level. The gene discussed is PDCD1; the disease is invasive breast carcinoma.